{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:02:16Z","timestamp":1792648936294,"version":"4.5.0"},"reference-count":192,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2020.00057","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T04:27:53Z","timestamp":1582604873000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":131,"title":["Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease"],"prefix":"10.3389","volume":"7","author":[{"given":"Alison W.","family":"Rebman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Aucott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.idc.2015.02.010","article-title":"Epidemiology of Lyme disease","volume":"29","author":"Mead","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"B2","doi-asserted-by":"publisher","first-page":"16090","DOI":"10.1038\/nrdp.2016.90","article-title":"Lyme borreliosis","volume":"2","author":"Steere","year":"2016","journal-title":"Nat Rev Dis Prim"},{"key":"B3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/cid\/ciu397","article-title":"Lyme disease testing by large commercial laboratories in the United States","volume":"59","author":"Hinckley","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1289\/ehp.1307799","article-title":"Estimated effects of projected climate change on the basic reproductive number of the Lyme disease vector Ixodes scapularis","volume":"122","author":"Ogden","year":"2014","journal-title":"Env Heal Perspect"},{"key":"B5","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1089\/vbz.2017.2127","article-title":"Brave new worlds: the expanding universe of Lyme disease","volume":"17","author":"Stone","year":"2017","journal-title":"Vector-Borne Zoonotic Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.14745\/ccdr.v43i10a01","article-title":"Surveillance for Lyme disease in Canada: 2009\u20132015","volume":"43","author":"Gasmi","year":"2017","journal-title":"Canada Commun Dis Rep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.14745\/ccdr.v44i10a01","article-title":"The continued rise of Lyme disease in Ontario, Canada: 2017","volume":"44","author":"Nelder","year":"2018","journal-title":"Canada Commun Dis Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s00508-006-0688-9","article-title":"Hematogenous dissemination in early Lyme disease","volume":"118","author":"Wormser","year":"2006","journal-title":"Wien Klin Wochenschr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/art.1780200102","article-title":"Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities","volume":"20","author":"Steere","year":"1977","journal-title":"Arthritis Rheum"},{"key":"B10","doi-asserted-by":"publisher","first-page":"725","DOI":"10.7326\/0003-4819-107-5-725","article-title":"The clinical evolution of Lyme arthritis","volume":"107","author":"Steere","year":"1987","journal-title":"Ann Intern Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1471-2334-12-173","article-title":"Probable late Lyme disease: a variant manifestation of untreated Borrelia burgdorferi infection","volume":"12","author":"Aucott","year":"2012","journal-title":"BMC Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3201\/2207.151694","article-title":"Current guidelines, common clinical pitfalls, and future directions for laboratory diagnosis of Lyme disease, United States","volume":"22","author":"Moore","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1128\/CMR.18.3.484-509.2005","article-title":"Diagnosis of Lyme borreliosis","volume":"18","author":"Aguero-Rosenfeld","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"785","DOI":"10.7326\/0003-4819-124-9-199605010-00002","article-title":"Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial","volume":"124","author":"Luft","year":"1996","journal-title":"Ann Intern Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.7326\/0003-4819-117-4-273","article-title":"Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease","volume":"117","author":"Robert","year":"1992","journal-title":"Ann Intern Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/0140-6736(90)93103-V","article-title":"Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis","volume":"336","author":"Dattwyler","year":"1990","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00508-005-0361-8","article-title":"A comparison of two treatment regimens of ceftriaxone in late Lyme disease","volume":"117","author":"Dattwyler","year":"2005","journal-title":"Wien Klin Wochenschr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"697","DOI":"10.7326\/0003-4819-138-9-200305060-00005","article-title":"Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial","volume":"138","author":"Wormser","year":"2003","journal-title":"Ann Intern Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1128\/AAC.39.3.661","article-title":"Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans","volume":"39","author":"Luger","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"B21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1056\/NEJM199707313370501","article-title":"Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease","volume":"337","author":"Dattwyler","year":"1997","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1056\/NEJM199610243351703","article-title":"Lyme disease in children in southeastern Connecticut","volume":"335","author":"Gerber","year":"1996","journal-title":"N Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11136-012-0126-6","article-title":"Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?","volume":"22","author":"Aucott","year":"2013","journal-title":"Qual Life Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1093\/cid\/civ735","article-title":"Long-term assessment of post-treatment symptoms in patients with culture-confirmed early Lyme disease","volume":"61","author":"Weitzner","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/nm1108-1135","article-title":"The chronic debate over Lyme disease","volume":"14","author":"Ballantyne","year":"2008","journal-title":"Nat Med"},{"key":"B26","first-page":"215","article-title":"The Lyme wars: the effects of biocommunicability, gender, and epistemic politics on health activation and Lyme science","volume-title":"Diagnostic Controversy: Cultural Perspectives on Competing Knowledge in Healthcare","author":"Davis","year":"2015"},{"key":"B27","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2217\/17460913.3.6.621","article-title":"Chronic Lyme disease and the \u201caxis of evil","volume":"3","author":"Stricker","year":"2008","journal-title":"Futur Microbiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1586\/eri.11.63","article-title":"Chronic Lyme disease: the controversies and the science","volume":"9","author":"Lantos","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"B29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.7326\/0003-4819-99-1-22","article-title":"Treatment of the early manifestations of Lyme disease","volume":"99","author":"Steere","year":"1983","journal-title":"Ann Intern Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/art.1780300414","article-title":"Failure of tetracycline therapy in early Lyme disease","volume":"30","author":"Dattwyler","year":"1987","journal-title":"Arthritis Rheum"},{"key":"B31","first-page":"454","article-title":"Lyme disease: an infectious and postinfectious syndrome","volume":"21","author":"Asch","year":"1994","journal-title":"J Rheumatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"560","DOI":"10.7326\/0003-4819-121-8-199410150-00002","article-title":"The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study","volume":"121","author":"Shadick","year":"1994","journal-title":"Ann Intern Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"919","DOI":"10.7326\/0003-4819-131-12-199912210-00003","article-title":"Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease","volume":"131","author":"Shadick","year":"1999","journal-title":"Ann Intern Med"},{"key":"B34","unstructured":"Lyme Disease Surveillance and Available Data"},{"key":"B35","unstructured":"29543607Lyme Disease Data and Surveillance"},{"key":"B36","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12889-019-6681-9","article-title":"Estimation of cumulative number of post-treatment Lyme disease cases in the US, 2016 and 2020","volume":"19","author":"DeLong","year":"2019","journal-title":"BMC Public Health"},{"key":"B37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0002-9343(03)00308-5","article-title":"Long-term follow-up of patients with culture-confirmed Lyme disease","volume":"115","author":"Nowakowski","year":"2003","journal-title":"Am J Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1086\/318082","article-title":"Evaluation of study patients with Lyme disease, 10-20-year follow-up","volume":"183","author":"Kalish","year":"2001","journal-title":"J Infect Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1093\/cid\/ciw189","article-title":"Long-term follow-up of patients with Lyme disease: longitudinal analysis of clinical and quality-of-life measures","volume":"62","author":"Wills","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3322\/caac.21342","article-title":"The impact of comorbidity on cancer and its treatment","volume":"66","author":"Sarfati","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"B41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40248-019-0172-9","article-title":"Obstructive sleep apnea and comorbidities: a dangerous liaison","volume":"14","author":"Bonsignore","year":"2019","journal-title":"Multidiscip Respir Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e021367","DOI":"10.1136\/bmjopen-2017-021367","article-title":"Obstacles to diagnosis and treatment of Lyme disease in the USA: a qualitative study","volume":"8","author":"Hirsch","year":"2018","journal-title":"BMJ Open"},{"key":"B43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2334-9-79","article-title":"Diagnostic challenges of early Lyme disease: lessons from a community case series","volume":"9","author":"Aucott","year":"2009","journal-title":"BMC Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/lary.26273","article-title":"Steroid use in Lyme disease-associated facial palsy is associated with worse long-term outcomes","volume":"127","author":"Jowett","year":"2017","journal-title":"Laryngoscope"},{"key":"B45","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.diagmicrobio.2018.03.016","article-title":"Outcome of facial palsy from Lyme disease in prospectively followed patients who had received corticosteroids","volume":"91","author":"Wormser","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.3389\/fimmu.2018.01634","article-title":"Robust B cell responses predict rapid resolution of Lyme disease","volume":"9","author":"Blum","year":"2018","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1128\/CVI.00071-16","article-title":"CCL19 as a chemokine risk factor for posttreatment Lyme disease syndrome: a prospective clinical cohort study","volume":"23","author":"Aucott","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/cid\/cit735","article-title":"Elevated levels of IL-23 in a subset of patients with post-Lyme disease symptoms following erythema migrans","volume":"58","author":"Strle","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.idc.2007.12.013","article-title":"Biology of infection with Borrelia burgdorferi","volume":"22","author":"Tilly","year":"2008","journal-title":"Infect Dis Clin North Am"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e10650","DOI":"10.1371\/journal.pone.0010650","article-title":"Genotypic variation and mixtures of Lyme Borrelia in Ixodes ticks from North America and Europe","volume":"5","author":"Crowder","year":"2010","journal-title":"PLoS ONE"},{"key":"B51","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1128\/IAI.67.7.3518-3524.1999","article-title":"Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans","volume":"67","author":"Seinost","year":"1999","journal-title":"Infect Immun"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1086\/592279","article-title":"Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease","volume":"198","author":"Wormser","year":"2008","journal-title":"J Infect Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1002\/art.22131","article-title":"Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis","volume":"54","author":"Steere","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.ajpath.2011.02.018","article-title":"Borrelia burgdorferi RST1 (OspC type A) genotype is associated with greater inflammation and more severe Lyme disease","volume":"178","author":"Strle","year":"2011","journal-title":"Am J Pathol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e00237","DOI":"10.1128\/AAC.00237-19","article-title":"Molecular testing of serial blood specimens from patients with early Lyme disease during treatment reveals changing co-infection with mixtures of Borrelia burgdorferi genotypes","volume":"63","author":"Mosel","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1001\/archderm.135.11.1329","article-title":"Infection with multiple strains of Borrelia burgdorferi sensu stricto in patients with Lyme disease","volume":"135","author":"Seinost","year":"1999","journal-title":"Arch Dermatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1001\/jama.1996.03530450047031","article-title":"Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness","volume":"275","author":"Krause","year":"1996","journal-title":"JAMA"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6622a1","article-title":"Surveillance for Lyme Disease - United States, 2008-2015","volume":"66","author":"Schwartz","year":"2017","journal-title":"MMWR Surveill Summ"},{"key":"B59","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.diagmicrobio.2016.04.012","article-title":"Comparison of males versus females with culture-confirmed early Lyme disease at presentation and at 11\u201320 years after diagnosis","volume":"85","author":"Weitzner","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3389\/fmed.2017.00224","article-title":"The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with posttreatment Lyme disease syndrome","volume":"4","author":"Rebman","year":"2017","journal-title":"Front Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1089\/jwh.2008.1193","article-title":"Implications of gender in chronic Lyme disease","volume":"18","author":"Wormser","year":"2009","journal-title":"J Womens Heal"},{"key":"B62","first-page":"2249","article-title":"Outcomes of children treated for Lyme disease","volume":"25","author":"Wang","year":"1998","journal-title":"J Rheumatol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1207\/s15324826an0601_6","article-title":"Long-term cognitive effects of Lyme disease in children","volume":"6","author":"Adams","year":"1999","journal-title":"Appl Neuropsychol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1542\/peds.102.4.905","article-title":"Lyme arthritis in children: clinical epidemiology and long-term outcomes","volume":"102","author":"Gerber","year":"1998","journal-title":"Pediatrics"},{"key":"B65","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.diagmicrobio.2017.09.007","article-title":"Impact of patient age on clinical features, serologic test reactivity and long-term outcome of culture-confirmed early Lyme disease","volume":"89","author":"Weitzner","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B66","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ttbdis.2018.10.010","article-title":"Epidemiology of Lyme disease in Pennsylvania 2006-2014 using electronic health records","volume":"10","author":"Moon","year":"2019","journal-title":"Ticks Tick Borne Dis"},{"key":"B67","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.idc.2015.02.006","article-title":"Chronic Lyme disease","volume":"29","author":"Lantos","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/cid\/ciu106","article-title":"Lyme disease: neurology, neurobiology, and behavior","volume":"58","author":"Halperin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa1114362","article-title":"Differentiation of reinfection from relapse in recurrent Lyme disease","volume":"367","author":"Nadelman","year":"2012","journal-title":"N Engl J Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1067\/mem.2002.119509","article-title":"Lyme disease masquerading as brown recluse spider bite","volume":"39","author":"Osterhoudt","year":"2002","journal-title":"Ann Emerg Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.4081\/or.2011.e14","article-title":"Misdiagnosis of early Lyme disease as the summer flu","volume":"3","author":"Aucott","year":"2011","journal-title":"Orthop Rev"},{"key":"B72","doi-asserted-by":"publisher","first-page":"838","DOI":"10.7326\/0003-4819-134-9_Part_2-200105011-00007","article-title":"Chronic fatigue: symptom and syndrome","volume":"134","author":"Wessely","year":"2001","journal-title":"Ann Intern Med"},{"key":"B73","first-page":"E257","article-title":"Prevalence of specific types of pain diagnoses in a sample of United States adults","volume":"20","author":"Murphy","year":"2017","journal-title":"Pain Physician"},{"key":"B74","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40359-018-0236-1","article-title":"Memory-related subjective cognitive symptoms in the adult population: prevalence and associated factors - results of the LIFE-Adult-Study","volume":"6","author":"Luck","year":"2018","journal-title":"BMC Psychol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1212\/WNL.42.7.1263","article-title":"Memory impairment and depression in patients with Lyme encephalopathy: comparison with fibromyalgia and nonpsychotically depressed patients","volume":"42","author":"Kaplan","year":"1992","journal-title":"Neurology"},{"key":"B76","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1529-0131(199902)12:1<42::AID-ART7>3.0.CO;2-3","article-title":"The Fibromyalgia Impact Questionnaire: a useful tool in evaluating patients with post-Lyme disease syndrome","volume":"12","author":"Fallon","year":"1999","journal-title":"Arthritis Care Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1001\/archneur.1997.00550230045015","article-title":"Post-Lyme syndrome and chronic fatigue syndrome. Neuropsychiatric similarities and differences","volume":"54","author":"Gaudino","year":"1997","journal-title":"Arch Neurol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3389\/fmed.2019.00283","article-title":"The General Symptom Questionnaire-30 (GSQ-30): a brief measure of multi-system symptom burden in Lyme disease","volume":"6","author":"Fallon","year":"2019","journal-title":"Front Med"},{"key":"B79","volume-title":"How to Score Version 2 of the SF-36 Health Survey","author":"Ware","year":"2000"},{"key":"B80","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease","volume":"345","author":"Klempner","year":"2001","journal-title":"N Engl J Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.psym.2013.04.003","article-title":"Correlates of perceived health-related quality of life in post-treatment Lyme encephalopathy","volume":"54","author":"Chandra","year":"2013","journal-title":"Psychosomatics"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch Neurol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","article-title":"Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial","volume":"60","author":"Krupp","year":"2003","journal-title":"Neurology"},{"key":"B84","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/MJT.0b013e3181da0763","article-title":"Postural orthostatic tachycardia syndrome following Lyme disease","volume":"18","author":"Kanjwal","year":"2011","journal-title":"Cardiol J"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.pain.2014.04.024","article-title":"Acute and chronic pain associated with Lyme borreliosis: clinical characteristics and pathophysiologic mechanisms","volume":"155","author":"Zimering","year":"2014","journal-title":"Pain"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1093\/ije\/dyi129","article-title":"Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms","volume":"34","author":"Cairns","year":"2005","journal-title":"Int J Epidemiol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/art.38972","article-title":"Long-term assessment of fibromyalgia in patients with culture-confirmed Lyme disease","volume":"67","author":"Wormser","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1177\/2150131914540693","article-title":"New insights into stages of Lyme disease symptoms from a novel hospital-based registry","volume":"5","author":"Lobraico","year":"2014","journal-title":"J Prim Care Community Heal"},{"key":"B89","doi-asserted-by":"publisher","first-page":"281","DOI":"10.7326\/0003-4819-117-4-281","article-title":"Lyme disease associated with fibromyalgia","volume":"117","author":"Dinerman","year":"1992","journal-title":"Ann Intern Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/0002-9343(90)90520-N","article-title":"Summary of the first 100 patients seen at a Lyme disease referral center","volume":"88","author":"Sigal","year":"1990","journal-title":"Am J Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1001\/jama.269.14.1812","article-title":"The overdiagnosis of Lyme disease","volume":"269","author":"Steere","year":"1993","journal-title":"JAMA"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1542\/peds.112.2.e93","article-title":"Long-term neuropsychologic and health outcomes of children with facial nerve palsy attributable to Lyme disease","volume":"112","author":"Vazquez","year":"2003","journal-title":"Pediatrics"},{"key":"B93","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cmi.2018.09.016","article-title":"Non-specific symptoms in adult patients referred to a Lyme centre","volume":"25","author":"Zomer","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1002\/art.40039","article-title":"MicroRNA expression shows inflammatory dysregulation and tumor-like proliferative responses in joints of patients with postinfectious Lyme arthritis","volume":"69","author":"Lochhead","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1093\/cid\/cix002","article-title":"T-Helper 17 cell cytokine responses in Lyme disease correlate with Borrelia burgdorferi antibodies during early infection and with autoantibodies late in the illness in patients with antibiotic-refractory Lyme arthritis","volume":"64","author":"Strle","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B96","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.clim.2015.07.005","article-title":"Annexin A2 is a target of autoimmune T and B cell responses associated with synovial fibroblast proliferation in patients with antibiotic-refractory Lyme arthritis","volume":"160","author":"Pianta","year":"2015","journal-title":"Clin Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/art.39866","article-title":"Autoimmune arthritides, rheumatoid arthritis, psoriatic arthritis, or peripheral spondyloarthritis following Lyme Disease","volume":"69","author":"Arvikar","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/00365540110080421","article-title":"5-y Follow-up study of patients with neuroborreliosis","volume":"34","author":"Berglund","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1056\/NEJM199011223232102","article-title":"Chronic neurologic manifestations of Lyme disease","volume":"323","author":"Logigian","year":"1990","journal-title":"N Engl J Med"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3389\/fneur.2019.01172","article-title":"Vertigo and severe balance instability as symptoms of Lyme disease\u2014literature review and case report","volume":"10","author":"Jozefowicz-Korczynska","year":"2019","journal-title":"Front Neurol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/01.AUD.0000100205.25774.5F","article-title":"Audiologic manifestations of patients with post-treatment Lyme disease syndrome","volume":"24","author":"Shotland","year":"2003","journal-title":"Ear Hear"},{"key":"B102","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1212\/WNL.42.2.303","article-title":"Clinical and electrophysiologic findings in chronic neuropathy of Lyme disease","volume":"42","author":"Logigian","year":"1992","journal-title":"Neurology"},{"key":"B103","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1136\/jnnp.65.5.743","article-title":"Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. European Inflammatory Neuropathy Cause and Treatment (INCAT) group","volume":"65","author":"Martina","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B104","doi-asserted-by":"publisher","first-page":"e0212222","DOI":"10.1371\/journal.pone.0212222","article-title":"Association of small fiber neuropathy and post treatment Lyme disease syndrome","volume":"14","author":"Novak","year":"2019","journal-title":"PLoS ONE"},{"key":"B105","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/anec.12158","article-title":"A tale of two syndromes: Lyme disease preceding postural orthostatic tachycardia syndrome","volume":"20","author":"Noyes","year":"2015","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/cid\/ciw599","article-title":"Expression of C-reactive protein and serum amyloid A in early to late manifestations of Lyme disease","volume":"63","author":"Uhde","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B107","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/0033354919890024","article-title":"Evaluating the potential misuse of the Lyme disease surveillance case definition","volume":"135","author":"Perea","year":"2020","journal-title":"Public Health Rep"},{"key":"B108","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10096-004-1163-z","article-title":"Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis","volume":"23","author":"Fleming","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B109","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1086\/322669","article-title":"Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease","volume":"33","author":"Kalish","year":"2001","journal-title":"Clin Infect Dis"},{"key":"B110","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1056\/NEJM198908313210906","article-title":"Lyme disease","volume":"345","author":"Steere","year":"1989","journal-title":"N Engl J Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1093\/cid\/ciy614","article-title":"Direct diagnostic tests for Lyme disease","volume":"68","author":"Schutzer","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1128\/AAC.01050-07","article-title":"Persistence of Borrelia burgdorferi following antibiotic treatment in mice","volume":"52","author":"Hodzic","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"B113","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ijpara.2018.11.007","article-title":"Human babesiosis","volume":"49","author":"Krause","year":"2019","journal-title":"Int J Parasitol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.amjmed.2014.05.036","article-title":"Chronic coinfections in patients diagnosed with chronic lyme disease: a systematic review","volume":"127","author":"Lantos","year":"2014","journal-title":"Am J Med"},{"key":"B115","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3201\/eid1603.081685","article-title":"Potential for tick-borne bartonelloses","volume":"16","author":"Angelakis","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"B116","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/IJGM.S193608","article-title":"Precision medicine: retrospective chart review and data analysis of 200 patients on dapsone combination therapy for chronic Lyme disease\/post-treatment Lyme disease syndrome: part 1","volume":"12","author":"Horowitz","year":"2019","journal-title":"Int J Gen Med"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1212\/WNL.40.9.1340","article-title":"Lyme borreliosis-associated encephalopathy","volume":"40","author":"Halperin","year":"1990","journal-title":"Neurology"},{"key":"B118","first-page":"479","article-title":"Lyme disease of the CNS: MR imaging findings in 14 cases","volume":"11","author":"Fernandez","year":"1990","journal-title":"AJNR Am J Neuroradiol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1749-6632.1988.tb31835.x","article-title":"Nervous system abnormalities in Lyme disease","volume":"539","author":"Halperin","year":"1988","journal-title":"Ann N Y Acad Sci"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3174\/ajnr.A1579","article-title":"Lyme neuroborreliosis: manifestations of a rapidly emerging zoonosis","volume":"30","author":"Hildenbrand","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/02841850701367903","article-title":"Brain magnetic resonance imaging does not contribute to the diagnosis of chronic neuroborreliosis","volume":"48","author":"Aalto","year":"2007","journal-title":"Acta Radiol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1212\/WNL.57.11.1980","article-title":"FLAIR and magnetization transfer imaging of patients with post-treatment Lyme disease syndrome","volume":"57","author":"Morgen","year":"2001","journal-title":"Neurology"},{"key":"B123","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1097\/RLU.0b013e318262ad9b","article-title":"SPECT brain imaging in chronic Lyme disease","volume":"37","author":"Donta","year":"2012","journal-title":"Clin Nucl Med"},{"key":"B124","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1176\/jnp.15.3.326","article-title":"Regional cerebral blood flow and cognitive deficits in chronic lyme disease","volume":"15","author":"Fallon","year":"2003","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"B125","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1001\/archgenpsychiatry.2009.29","article-title":"Regional cerebral blood flow and metabolic rate in persistent Lyme encephalopathy","volume":"66","author":"Fallon","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"B126","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s13244-018-0646-x","article-title":"Imaging in Lyme neuroborreliosis","volume":"9","author":"Lindland","year":"2018","journal-title":"Insights Imaging"},{"key":"B127","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12974-018-1381-4","article-title":"Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [ 11 C]DPA-713 PET","volume":"15","author":"Coughlin","year":"2018","journal-title":"J Neuroinflammation"},{"key":"B128","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/arclin\/acy051","article-title":"Cognitive decline in post-treatment Lyme disease syndrome","volume":"34","author":"Touradji","year":"2019","journal-title":"Arch Clin Neuropsychol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1023\/A:1020381913563","article-title":"Neuropsychological functioning in chronic Lyme disease","volume":"12","author":"Westervelt","year":"2002","journal-title":"Neuropsychol Rev"},{"key":"B130","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1017\/S1355617706060231","article-title":"WAIS-III and WMS-III performance in chronic Lyme disease","volume":"12","author":"Keilp","year":"2006","journal-title":"J Int Neuropsychol Soc"},{"key":"B131","first-page":"72","article-title":"Cognitive processing speed in Lyme disease","volume":"12","author":"Pollina","year":"1999","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/arclin\/acy083","article-title":"Neurocognition in post-treatment Lyme disease and major depressive disorder","volume":"34","author":"Keilp","year":"2019","journal-title":"Arch Clin Neuropsychol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1207\/s15324826an0601_1","article-title":"Neuropsychological deficits in Lyme disease patients with and without other evidence of central nervous system pathology","volume":"6","author":"Kaplan","year":"1999","journal-title":"Appl Neuropsychol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1207\/s15324826an0601_3","article-title":"Psychological states and neuropsychological performances in chronic Lyme disease","volume":"6","author":"Elkins","year":"1999","journal-title":"Appl Neuropsychol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1212\/01.WNL.0000068030.26992.25","article-title":"Cognitive function in post-treatment Lyme disease Do additional antibiotics help?","volume":"60","author":"Kaplan","year":"2003","journal-title":"Neurology"},{"key":"B136","doi-asserted-by":"publisher","first-page":"e93243","DOI":"10.1371\/journal.pone.0093243","article-title":"Serum inflammatory mediators as markers of human Lyme disease activity","volume":"9","author":"Soloski","year":"2014","journal-title":"PLoS ONE"},{"key":"B137","first-page":"125","article-title":"Stationary phase persister\/biofilm microcolony of Borrelia burgdorferi causes more severe disease in a mouse model of Lyme arthritis: implications for understanding persistence, Post-treatment Lyme Disease Syndrome (PTLDS), and treatment failure","volume":"27","author":"Feng","year":"2019","journal-title":"Discov Med"},{"key":"B138","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1128\/AAC.00864-15","article-title":"Borrelia burgdorferi, the causative agent of Lyme disease, forms drug-tolerant persister cells","volume":"59","author":"Sharma","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"B139","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ajpath.2017.11.005","article-title":"Late disseminated Lyme disease: associated pathology and spirochete persistence posttreatment in Rhesus Macaques","volume":"188","author":"Crossland","year":"2018","journal-title":"Am J Pathol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"e86907","DOI":"10.1371\/journal.pone.0086907","article-title":"Resurgence of persisting non-cultivable Borrelia burgdorferi following antibiotic treatment in mice","volume":"9","author":"Hodzic","year":"2014","journal-title":"PLoS ONE"},{"key":"B141","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/JCM.35.1.111-116.1997","article-title":"Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment","volume":"35","author":"Straubinger","year":"1997","journal-title":"J Clin Microbiol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1086\/345284","article-title":"Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment","volume":"186","author":"Bockenstedt","year":"2002","journal-title":"J Infect Dis"},{"key":"B143","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1172\/JCI58813","article-title":"Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy","volume":"122","author":"Bockenstedt","year":"2012","journal-title":"J Clin Invest"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.4049\/jimmunol.1701248","article-title":"IL-10 deficiency reveals a role for TLR2-dependent bystander activation of T cells in Lyme arthritis","volume":"200","author":"Whiteside","year":"2018","journal-title":"J Immunol"},{"key":"B145","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1002\/1529-0131(199912)42:12<2705::AID-ANR29>3.0.CO;2-H","article-title":"Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis","volume":"42","author":"Carlson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"B146","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1006\/jaut.2000.0495","article-title":"Autoimmune mechanisms in antibiotic treatment-resistant Lyme arthritis","volume":"16","author":"Steere","year":"2001","journal-title":"J Autoimmun"},{"key":"B147","doi-asserted-by":"publisher","first-page":"13498","DOI":"10.1073\/pnas.1904170116","article-title":"Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis","volume":"116","author":"Jutras","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B148","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s10067-012-1964-x","article-title":"The amber theory of Lyme arthritis: initial description and clinical implications","volume":"31","author":"Wormser","year":"2012","journal-title":"Clin Rheumatol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.bbi.2010.03.002","article-title":"Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms","volume":"24","author":"Chandra","year":"2010","journal-title":"Brain Behav Immun"},{"key":"B150","doi-asserted-by":"publisher","first-page":"e17287","DOI":"10.1371\/journal.pone.0017287","article-title":"Distinct cerebrospinal fluid proteomes differentiate post-treatment Lyme disease from chronic fatigue syndrome","volume":"6","author":"Schutzer","year":"2011","journal-title":"PLoS ONE"},{"key":"B151","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/bmj.38933.585764.AE","article-title":"Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study","volume":"333","author":"Hickie","year":"2006","journal-title":"BMJ"},{"key":"B152","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1176\/appi.neuropsych.12090223","article-title":"Post-treatment Lyme syndrome and central sensitization","volume":"25","author":"Batheja","year":"2013","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"B153","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1177\/1049732315619380","article-title":"Living in limbo: contested narratives of patients with chronic symptoms following Lyme disease","volume":"27","author":"Rebman","year":"2017","journal-title":"Qual Health Res"},{"key":"B154","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","article-title":"A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy","volume":"70","author":"Fallon","year":"2008","journal-title":"Neurology"},{"key":"B155","first-page":"489","article-title":"Severity of Lyme disease with persistent symptoms. Insights from a double-blind placebo-controlled clinical trial","volume":"99","author":"Cameron","year":"2008","journal-title":"Minerva Med"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa1505425","article-title":"Randomized trial of longer-term therapy for symptoms attributed to Lyme disease","volume":"374","author":"Evers","year":"2016","journal-title":"N Engl J Med"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.cct.2012.08.009","article-title":"Antibiotic retreatment of Lyme disease in patients with persistent symptoms: a biostatistical review of randomized, placebo-controlled, clinical trials","volume":"33","author":"Delong","year":"2012","journal-title":"Contemp Clin Trials"},{"key":"B158","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/1874205X01206010079","article-title":"A reappraisal of the U.S. clinical trials of post-treatment Lyme disease syndrome","volume":"6","author":"Fallon","year":"2012","journal-title":"Open Neurol J"},{"key":"B159","doi-asserted-by":"publisher","first-page":"607","DOI":"10.15585\/mmwr.mm6623a3","article-title":"Serious bacterial infections acquired during treatment of patients given a diagnosis of chronic Lyme Disease \u2014 United States","volume":"66","author":"Marzec","year":"2017","journal-title":"Morb Mortal Wkly Rep"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1086\/318138","article-title":"Death from inappropriate therapy for Lyme disease","volume":"31","author":"Patel","year":"2000","journal-title":"Clin Infect Dis"},{"key":"B161","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1086\/518854","article-title":"Point: antibiotic therapy is not the answer for patients with persisting symptoms attributable to Lyme disease","volume":"45","author":"Auwaerter","year":"2007","journal-title":"Clin Infect Dis"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1586\/14787210.2014.940900","article-title":"Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease","volume":"12","author":"Cameron","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"B163","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/antibiotics8040269","article-title":"Chronic Lyme disease: an evidence-based definition by the ILADS working group","volume":"8","author":"Shor","year":"2019","journal-title":"Antibiot"},{"key":"B164","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00415-002-0765-6","article-title":"Modafinil in treatment of fatigue in multiple sclerosis: results of an open-label study","volume":"249","author":"Zifko","year":"2002","journal-title":"J Neurol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"e0221897","DOI":"10.1371\/journal.pone.0221897","article-title":"Mindfulness- and acceptance-based interventions for patients with fibromyalgia - A systematic review and meta-analyses","volume":"14","author":"Haugmark","year":"2019","journal-title":"PLoS ONE"},{"key":"B166","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1249\/MSS.0000000000000683","article-title":"Supervised resistance exercise for patients with persistent symptoms of Lyme disease","volume":"47","author":"D'Adamo","year":"2015","journal-title":"Med Sci Sports Exerc"},{"key":"B167","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3389\/fmed.2017.00169","article-title":"Selective essential oils from spice or culinary herbs have high activity against stationary phase and biofilm Borrelia burgdorferi","volume":"4","author":"Feng","year":"2017","journal-title":"Front Med"},{"key":"B168","doi-asserted-by":"publisher","first-page":"e01201","DOI":"10.1128\/AAC.01201-18","article-title":"Identifying vancomycin as an effective antibiotic for killing Borrelia burgdorferi","volume":"62","author":"Wu","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.2147\/DDDT.S101486","article-title":"Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening","volume":"10","author":"Pothineni","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"B170","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1038\/emi.2014.53","article-title":"Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library","volume":"3","author":"Feng","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"B171","doi-asserted-by":"publisher","first-page":"e0117207","DOI":"10.1371\/journal.pone.0117207","article-title":"Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline","volume":"10","author":"Feng","year":"2015","journal-title":"PLoS ONE"},{"key":"B172","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.idc.2015.02.012","article-title":"Posttreatment Lyme disease syndrome","volume":"29","author":"Aucott","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"B173","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.idc.2015.02.004","article-title":"Diagnosis and treatment of Lyme arthritis","volume":"29","author":"Arvikar","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1056\/NEJMra072023","article-title":"A critical appraisal of \u201cchronic Lyme disease","volume":"357","author":"Feder","year":"2007","journal-title":"N Engl J Med"},{"key":"B175","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01459740.2019.1670175","article-title":"Lyme Disease and the epistemic tensions of \u201cmedically unexplained illnesses\u201d","author":"Dumes","year":"2019","journal-title":"Med Anthropol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1001\/archfami.9.6.563","article-title":"Failure of treatment with cephalexin for Lyme disease","volume":"9","author":"Nowakowski","year":"2000","journal-title":"Arch Fam Med"},{"key":"B177","first-page":"441","article-title":"Delayed diagnosis of neuroborreliosis presenting as bell palsy and meningitis","volume":"110","author":"Smith","year":"2010","journal-title":"JAOA J Am"},{"key":"B178","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1016\/j.jemermed.2017.09.005","article-title":"Early disseminated Lyme disease masquerading as mononucleosis: a case report","volume":"53","author":"Tumminello","year":"2017","journal-title":"J Emerg Med"},{"key":"B179","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/cid\/cix298","article-title":"Early disseminated Lyme disease causing false-positive serology for primary Epstein-Barr virus infection: report of 2 cases","volume":"65","author":"Pavletic","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B180","doi-asserted-by":"publisher","first-page":"451727","DOI":"10.1155\/2012\/451727","article-title":"Bull's-Eye and nontarget skin lesions of Lyme disease: an internet survey of identification of erythema migrans","volume":"2012","author":"Aucott","year":"2012","journal-title":"Dermatol Res Pr"},{"key":"B181","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1001\/jama.297.23.2617","article-title":"Does this patient have erythema migrans?","volume":"297","author":"Tibbles","year":"2007","journal-title":"JAMA"},{"key":"B182","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D3218028428","article-title":"Vesicular erythema migrans: an atypical and easily misdiagnosed form of Lyme disease","volume":"21","author":"Mazori","year":"2015","journal-title":"Dermatol Online J"},{"key":"B183","doi-asserted-by":"publisher","first-page":"e0116767","DOI":"10.1371\/journal.pone.0116767","article-title":"Health care costs, utilization and patterns of care following Lyme disease","volume":"10","author":"Adrion","year":"2015","journal-title":"PLoS ONE"},{"key":"B184","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.healthpol.2011.05.007","article-title":"Healthcare access and burden of care for patients with Lyme disease: a large United States survey","volume":"102","author":"Johnson","year":"2011","journal-title":"Health Policy."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jpeds.2010.06.031","article-title":"Chronic Lyme disease: a survey of Connecticut primary care physicians","volume":"157","author":"Johnson","year":"2010","journal-title":"J Pediatr"},{"key":"B186","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.puhe.2014.06.016","article-title":"Lyme disease and post-treatment Lyme disease syndrome: the neglected disease in our own backyard","volume":"128","author":"Crowder","year":"2014","journal-title":"Public Health"},{"key":"B187","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1093\/cid\/civ186","article-title":"Unorthodox alternative therapies marketed to treat Lyme disease","volume":"60","author":"Lantos","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B188","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2296-15-79","article-title":"Experiences of patients identifying with chronic Lyme disease in the healthcare system: a qualitative study","volume":"15","author":"Ali","year":"2014","journal-title":"BMC Fam Pr"},{"key":"B189","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.0737-1209.2006.230104.x","article-title":"A qualitative approach to understanding patients' diagnosis of Lyme disease","volume":"23","author":"Drew","year":"2006","journal-title":"Public Heal Nurs"},{"key":"B190","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0277-9536(00)00014-9","article-title":"Concepts of trust among patients with serious illness","volume":"51","author":"Mechanic","year":"2000","journal-title":"Soc Sci Med"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.14m01664","article-title":"Impact of invalidation and trust in physicians on health outcomes in fibromyalgia patients","volume":"16","author":"Lobo","year":"2014","journal-title":"Prim Care Companion CNS Disord"},{"key":"B192","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2307\/3350122","article-title":"Lyme disease: the social construction of a new disease and its social consequences","volume":"69","author":"Aronowitz","year":"1991","journal-title":"Milbank Q"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00057\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,16]],"date-time":"2022-10-16T12:14:57Z","timestamp":1665922497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00057\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":192,"alternative-id":["10.3389\/fmed.2020.00057"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.00057","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,25]]},"article-number":"57"}}